Q2 2018 13F Holders as of 6/30/2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
22.2M
-
Number of holders
-
144
-
Total 13F shares, excl. options
-
8.03M
-
Shares change
-
+1.78M
-
Total reported value, excl. options
-
$2.24B
-
Value change
-
+$568M
-
Put/Call ratio
-
0.17
-
Number of buys
-
106
-
Number of sells
-
-46
-
Price
-
$279.69
Significant Holders of MADRIGAL PHARMACEUTICALS, INC. - Common Stock (MDGL) as of Q2 2018
165 filings reported holding MDGL - MADRIGAL PHARMACEUTICALS, INC. - Common Stock as of Q2 2018.
MADRIGAL PHARMACEUTICALS, INC. - Common Stock (MDGL) has 144 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 8.03M shares
of 22.2M outstanding shares and own 36.17% of the company stock.
Largest 10 shareholders include Capital Research Global Investors (1.37M shares), BAKER BROS. ADVISORS LP (1.17M shares), PRICE T ROWE ASSOCIATES INC /MD/ (568K shares), venBio Select Advisor LLC (490K shares), BlackRock Inc. (488K shares), VANGUARD GROUP INC (463K shares), STATE STREET CORP (343K shares), Rock Springs Capital Management LP (342K shares), EcoR1 Capital, LLC (200K shares), and HealthCor Management, L.P. (197K shares).
This table shows the top 144 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.